Sector Cardiol Therapeutics Inc.

Aandelen

CRDL

CA14161Y2006

Biotechnologie & Medisch Onderzoek

Beurs gesloten - 22:00:00 16-10-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
1,580 CAD -1,25% Intraday-grafiek van Cardiol Therapeutics Inc. -11,24% +20,61%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
-1,25%-11,24%-39,69%-9,20%+20,61%+8,22%+43,64%-70,52% - 132 mln.
-6,60%-10,93%-7,90%+9,73%+59,20%+45,08%+60,01%-0,71% - 68,98 mld.
-4,09%+3,12%-15,28%-3,06%+1,51%+3,71%+53,50%+185,00%+4.786,50% 53,15 mld.
+0,03%+7,21%+12,43%+3,89%+12,31%+12,52%+44,46%-16,32%+231,87% 50,83 mld.
-1,53%+2,70%-0,71%+26,80%+18,41%+29,72%+34,13%+7,42%+254,54% 44,61 mld.
-5,97%-6,22%-9,17%-0,68%+123,43%+258,21%+421,57%+535,57% - 40,57 mld.
-1,34%+4,12%+6,03%+16,27%+21,48%+16,05%+112,18%+2,29%+1.034,52% 42,53 mld.
+6,53%+8,02%+9,30%+10,42%+12,54%+18,98%+54,58%+7,26%+169,34% 30,95 mld.
-0,90%-10,91%-2,07%+21,90%+53,31%+34,11%-1,83%-55,94% - 25,44 mld.
-2,76%-9,54%-8,47%-4,20%-7,87%-16,53%-9,55%-66,41% - 22,66 mld.
-1,07%+6,20%+16,37%+31,96%+23,43%+20,52%+10,51%-12,27%+122,80% 22,65 mld.
-2,96%-4,30%-21,46%-10,41%-44,69%-41,01%+283,85%+265,21%+608,39% 21,67 mld.
-1,61%+1,05%+0,33%+14,97%+10,12%+18,66%+160,66%+232,83%+1.996,51% 17,55 mld.
+3,32%+4,18%+3,32%-5,68%+193,84%+168,17%+386,54%+1.614,31%+817,72% 15,42 mld.
-0,95%+3,96%+9,60%+11,76%+41,98%+58,71%+188,50%+192,02%+440,66% 15,57 mld.
-1,14%+3,38%+6,51%+12,93%+25,42%+26,55%+57,62%-27,90%+87,27% 15,4 mld.
-0,60%-1,74%-9,06%-13,30% - - - - - 14,88 mld.
-1,99%-0,54%+9,78%+30,98%+50,47%+71,56%+55,73%-27,50%+274,95% 14,62 mld.
+3,10%+1,39%-2,25%-15,75%+15,25%-3,54%+445,89% - - 13,35 mld.
-2,83%+3,66%-2,16%+0,11%-6,61%-9,70%-30,58%-38,47%+120,16% 13,51 mld.
Gemiddelde -1,24%+1,69%-2,23%+6,47%+32,85%+37,89%+124,81%+151,44%+841,94% 27,22 mld.
Gewogen gemiddelde per kap. -1,96%+2,18%-1,24%+8,17%+33,47%+41,91%+112,19%+124,90%+1.127,71%
  1. Beurs
  2. Aandelen
  3. Koers CRDL
  4. Sector Cardiol Therapeutics Inc.